Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
RAPT Therapeutics Inc. logo

RAPT Therapeutics Inc.

Sector: Professional, Scientific, and Technical Services   

Industry: Research and Development in Biotechnology

3.14
 
USD
  
0.05
  
(1.62%)
Optionable: Yes  Market Cap: 111 M  90-day average vol: 782,289

Previous close: 3.09  Open: 3.11  Bid: 3.17  Ask: 3.2
52 week range    
2.99   
   27.35
Last updated: Monday 24th June 2024

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock

🎉 Exciting news! 🎉

You are invited to join our Discord Channel.

Interact, learn, and grow with experts in the markets!

Join our Discord

Metrics

Peers

StockDividendMarket Cap (B)PEPrice ($)
Financials

RAPT Income Statement

Annual
Invalid dateDec-19Dec-20Dec-21Dec-22
Basic EPS from continuing operations-2.19-2.53-2.58
Basic EPS total-2.19-2.53-2.58
Basic weighted shares outstanding4 M24 M27 M33 M
Depreciation1 M1000000.01000000.0
Depreciation unreconciled-1 M
DepreciationAndAmortization-1 M1 M1000000.01000000.0
Diluted EPS total-9.89-2.19-2.53-2.58
Diluted normalized net income/share-2.58
Diluted weighted shares outstanding4 M24 M33 M
GeneralAndAdministrativeExpense9 M13 M16 M20 M
Gross operating profit5 M4 M2 M
Income before tax-42 M-52 M-69 M-84 M
Income taxes660000.0990000.0
Interest income1 M
MiscOtherSpecialCharges1 M5000.02 M
Net income from total operations-43 M-53 M-69 M-84 M
NetIncomeCommonStockholders-43 M-53 M-69 M-84 M
NetIncomeContinuousOperations-43 M-53 M-69 M-84 M
NetNonOperatingInterestIncomeExpense1 M
Normalized income-55 M-66 M
Operating income-44 M-53 M-69 M-86 M
Operating income before depreciation (EBITDA)-41 M-50 M-67 M-83 M
OperatingExpense-44 M58 M73 M87 M
Other income net-1 M-5000.0-2 M
OtherGandA9 M13 M16 M20 M
OtherOperatingExpenses-466000.0-544000.0-1 M-759000.0
RentAndLandingFees9 M
Research & development expense35 M45 M57 M67 M
ResearchExpense35 M45 M57 M67 M
SalariesAndWages-2 M
Selling Gen & administrative expense9 M13 M16 M20 M
Total Income available for interest expense (EBIT)-42 M-52 M-69 M-84 M
Total common shares outstanding24 M25 M30 M34 M
Total net income-43 M-53 M-69 M-84 M
Total ordinary shares35 M35 M35 M35 M
Total revenues5 M4 M2 M
TotalExpenses-44 M58 M73 M87 M
TotalRevenue5 M4 M2 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University